Parkinson, Cholesterol
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...
Experts from Huashan Hospital conduct Parkinson's disease research in a laboratory.
Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...
The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month ...
The Erling-Persson Foundation is donating SEK 8 million to KI researcher Johan Ericson to fund the verification of his ATMP ...
Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first treatment to slow the progression of Parkinson's disease.
HealthDay on MSN8d
Study Finds Exenatide Not Beneficial for Parkinson DiseaseNo evidence seen to support GLP-1 receptor agonist exenatide as disease-modifying treatment for Parkinson disease. HealthDay News — The glucagon-like peptide-1 receptor agonist exenatide does ...
A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results